Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected
- Status
- TERMINATED
- Phase
- PHASE3
Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
PITCHER (Peritoneal Carcinomatosis Heterogeneity)
- Status
- RECRUITING
- Phase
- N/A
Sentinel Lymph Node Assessment in Ovarian Cancer (TRSGO-SLN-OO5)
- Status
- UNKNOWN
- Phase
- NA
Lymphadenectomy in Early Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece
- Status
- COMPLETED
- Phase
- NA
A Study of PY314 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Trial on NIraparib-TSR-042 (Dostarlimab) vs Physician's Choice CHEmotherapy in Recurrent, Ovarian, Fallopian Tube or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment
- Status
- UNKNOWN
- Phase
- PHASE3
CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
- Status
- COMPLETED
- Phase
- PHASE3
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
EP0057 in Combination With Olaparib in Advanced Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
- Status
- COMPLETED
- Phase
- PHASE1